Related Experiment Video

Updated: Jun 1, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
09:50

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade

Published on: August 14, 2019

Anticancer properties of flavonoids: roles in various stages of carcinogenesis

Nicolas Clere1, Sébastien Faure, Maria Carmen Martinez

  • 1INSERM UMR U694, Université d'Angers, Angers, France.

Cardiovascular & Hematological Agents in Medicinal Chemistry
|June 8, 2011
PubMed

Insights

Fruits and vegetables contain flavonoids that may prevent cancer. This review explores the preventive and therapeutic effects of specific flavonoids like apigenin and genistein, based on in vitro and animal studies.

Area of Science:

  • Phytochemistry
  • Cancer Biology
  • Nutritional Science

Background:

  • Dietary intake of fruits and vegetables is linked to reduced cancer risk.
  • Phytochemicals, particularly flavonoids, are under investigation for their cancer-preventive mechanisms.
  • Carcinogenesis involves complex cellular processes including transformation, proliferation, and metastasis.

Purpose of the Study:

  • To review the preventive and therapeutic effects of specific flavonoids.
  • To elucidate the mechanisms by which flavonoids impact carcinogenesis.
  • To facilitate the extrapolation of findings from animal models to human health.

Main Methods:

  • Review of in vitro studies on flavonoid mechanisms.
  • Analysis of animal model data on flavonoid efficacy.
  • Examination of epidemiological evidence for flavonoid benefits.

Main Results:

  • Flavonoids modulate key cellular and molecular mechanisms in carcinogenesis.
  • Apigenin, epigallocatechin gallate, delphinidin, and genistein show promise in cancer prevention.
  • Evidence suggests flavonoids can impact tumor cell survival, proliferation, invasion, angiogenesis, and metastasis.

Conclusions:

  • Specific flavonoids demonstrate significant potential in cancer prevention and therapy.
  • Further research is needed to translate findings from preclinical studies to human applications.
  • Understanding flavonoid mechanisms can guide dietary recommendations for cancer risk reduction.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...